Yubal, Dasch H.
HRN: 18-91-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/26/2023
11/01/2023
IVT
1,200mg
Q8
Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes